The “How to Cover Money” podcast series, produced by The Reynolds Center for Business Journalism, is designed specifically for journalists who want to cover business better on their beats.
All content for We Mean Business is the property of BizJournalism and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The “How to Cover Money” podcast series, produced by The Reynolds Center for Business Journalism, is designed specifically for journalists who want to cover business better on their beats.
The FDA lets ‘risky drugs’ into the U.S. market, ProPublica reporter explains their investigation
We Mean Business
15 minutes 27 seconds
4 months ago
The FDA lets ‘risky drugs’ into the U.S. market, ProPublica reporter explains their investigation
The vast majority of drugs prescribed in the United States, including antidepressants, antibiotics, and sedatives, are generic drugs, many of which are manufactured in overseas factories. While the Food and Drug Administration (FDA) is tasked with enforcing drug safety standards and regulations, a ProPublica investigation found that many drugs still made it to the U.S. despite not meeting those standards.
In this episode, George Headley speaks with Northwestern professor and ProPublica reporter Debbie Cenziper, who, alongside a team of reporters including her students, published a series of stories about the FDA’s oversight of international drug companies. The team spent 14 months investigating the agency and found that it had allowed more than 150 drugs in the U.S. that should have been deemed too risky for distribution.
We Mean Business
The “How to Cover Money” podcast series, produced by The Reynolds Center for Business Journalism, is designed specifically for journalists who want to cover business better on their beats.